about
Stereotactic ablative radiotherapy for early stage non-small cell lung cancer: A critical literature review of predictive factors of relapse.Role of adjuvant radiotherapy in completely resected non-small-cell lung cancer.Key role of the endothelial TGF-β/ALK1/endoglin signaling pathway in humans and rodents pulmonary hypertension.Piglet model of chronic pulmonary hypertension.Sternal replacement with a custom-made titanium plate after resection of a solitary breast cancer metastasis.Validation of a scoring system to predict recurrence of resected solitary fibrous tumors of the pleuraThe beneficial effect of suramin on monocrotaline-induced pulmonary hypertension in ratsIncreased oxidative stress and severe arterial remodeling induced by permanent high-flow challenge in experimental pulmonary hypertension.Inactivation of p53 Is Sufficient to Induce Development of Pulmonary Hypertension in Rats.Osteopontin and thrombospondin-1 play opposite roles in promoting tumor aggressiveness of primary resected non-small cell lung cancer.Chronic thromboembolic pulmonary hypertension: animal models.Experimental models of right heart failure: a window for translational research in pulmonary hypertension.Lung and heart-lung transplantation for systemic sclerosis patients. A monocentric experience of 13 patients, review of the literature and position paper of a multidisciplinary Working Group.Advancing knowledge of right ventricular pathophysiology in chronic pressure overload: Insights from experimental studies.Pearls and pitfalls in managing right heart failure in cardiac surgery.Investigating the value of right heart echocardiographic metrics for detection of pulmonary hypertension in patients with advanced lung disease.BMPR2 mutation status influences bronchial vascular changes in pulmonary arterial hypertension.Right Heart End-Systolic Remodeling Index Strongly Predicts Outcomes in Pulmonary Arterial Hypertension: Comparison With Validated Models.Impact of High-Priority Allocation on Lung and Heart-Lung Transplantation for Pulmonary Hypertension.Lymphoproliferative Disorders after Lung Transplantation: Clinicopathological Characterization of 16 Cases with Identification of Very-Late-Onset Forms.Thermal pretreatments of superficially porous silica particles for high-performance liquid chromatography: Surface control, structural characterization and chromatographic evaluation.Outcomes After Resection of T4 Non-Small Cell Lung Cancer Using Cardiopulmonary Bypass.Extracorporeal Life Support After Pulmonary Endarterectomy as a Bridge to Recovery or Transplantation: Lessons From 31 Consecutive Patients.Endothelial cell apoptosis in chronically obstructed and reperfused pulmonary artery.Stereotactic ablative body radiation therapy or surgery for operable early non-small cell lung cancer patients: bound hand and foot to evidence.Chronic Thromboembolic Pulmonary Hypertension and Assessment of Right Ventricular Function in the Piglet.Long-term outcome after resection of non-small cell lung cancer invading the thoracic inlet.Non-invasive indices of right ventricular function are markers of ventricular-arterial coupling rather than ventricular contractility: insights from a porcine model of chronic pressure overload.Factors affecting early and long-term outcomes after completion pneumonectomy.Endovascular closure of Potts shunt before double lung transplantation for idiopathic pulmonary arterial hypertension.Outcomes of intraoperative extracorporeal membrane oxygenation versus cardiopulmonary bypass for lung transplantation.Septal curvature is marker of hemodynamic, anatomical, and electromechanical ventricular interdependence in patients with pulmonary arterial hypertension.Load Adaptability in Patients With Pulmonary Arterial Hypertension.Right ventricular plasticity in a porcine model of chronic pressure overload.Early Development of Right Ventricular Ischemic Lesions in a Novel Large Animal Model of Acute Right Heart Failure in Chronic Thromboembolic Pulmonary Hypertension.Report of the ISHLT Working Group on primary lung graft dysfunction Part IV: Prevention and treatment: A 2016 Consensus Group statement of the International Society for Heart and Lung Transplantation.Pulmonary vascular remodeling patterns and expression of general control nonderepressible 2 (GCN2) in pulmonary veno-occlusive disease.Computed tomography findings of pulmonary venoocclusive disease in scleroderma patients presenting with precapillary pulmonary hypertension.Thermoplastic elastomer with advanced hydrophilization and bonding performances for rapid (30 s) and easy molding of microfluidic devices.Right ventricular reserve in a piglet model of chronic pulmonary hypertension.
P50
Q30244240-2CD25829-2D80-432F-92FA-3D2D81AAB606Q33698439-4EBD39CF-5861-4125-8CEC-B63F52CE0625Q33793407-1AEDCDB7-F90D-41EF-BFA9-B62381B5BA7CQ33806241-DD07843C-F07B-419B-BD1E-5455CAF83D6CQ34038596-E2C52013-95C9-49EE-92D0-EF174BA33310Q34840380-E525251C-6892-46BD-A4B7-6C627FB7A070Q35021663-F8295BB6-C265-4A31-BF96-4CD248B3D599Q35289907-CA1D8F2C-2A70-481F-9261-99B80F6C46D8Q35677182-BB4ED790-F2D5-47B3-A5B8-E508ADAA84D2Q36079101-8DE52858-7920-4576-974B-3EAD99FCCC6BQ38073668-F79207A7-6329-49E0-9896-5170C6F0D84FQ38137788-2C95945A-5E09-4F85-B174-9FB3BE0C555BQ38229870-6E86964A-9E3D-45D1-8AF2-654ACB640FADQ38549127-B031E380-C169-4C28-91FC-4506E304354AQ38666787-32DB1D08-55A0-4D3B-9D21-E0F265DE706EQ39000872-78A3258E-B12F-4433-9899-04FE60CD2829Q39218460-6A6F6491-A4D9-43A4-9E82-2852597564DAQ40168224-EC68A004-0F8B-40C3-94B1-AF1274624CCBQ40192628-B79C1671-461A-44FD-B074-0A42F1FA9899Q40387149-10AC3AE5-C0D6-4305-9BBE-7B1AB0737746Q40444737-E2E5B617-F4C1-446A-A0B4-A6D02BAAAD26Q40742622-3F0193EE-DA0A-46B4-976B-4A93ACA35D88Q40782651-4EB14B27-3130-43D3-A387-6329455783D5Q41832700-74F41694-378B-4D16-8DF4-9D52896839D2Q42362383-FD10469D-95BB-40BA-AC2F-949AD570EB82Q43114841-4E38BF39-EC1D-4016-92AB-3A2924FAF5EBQ43501568-90F0AAFB-BDB7-4130-B6C2-26C74505DD83Q43583937-BC345E4F-6133-45BF-B2F9-D8F46720A602Q43986131-CE39E96E-4497-4376-8AB3-EAC891BDB1DEQ44182664-4078396C-EBD7-4C16-A6D3-755C5FE3EC15Q45140807-F4E6C146-E442-4436-8AA5-F521F063BB41Q46101526-4A745356-70BD-4549-AF2B-A04112E7FB2BQ46195121-341EE7AA-0773-4FD4-9A5E-F720A152A219Q46724533-921B2C25-212A-4472-9EA3-83E89D2AA6CDQ46738805-454886FB-EBD4-41CE-BAD0-FFD5910436EEQ46856227-B0E8ED07-04A7-4FC2-AAF2-FA392DD821F6Q47434868-BAC67A0A-82EC-4B6A-9E66-EEA96C05EF24Q47823670-B946E982-0DD0-4A83-BAC1-16EA1D2E58E4Q47980019-A80B689C-7C3B-4091-855A-9DF0ED5333ACQ48245697-13108181-C8C1-405A-AE28-6ED25DF6423B
P50
description
researcher, ORCID id # 0000-0002-4760-6267
@en
wetenschapper
@nl
name
Olaf Mercier
@ast
Olaf Mercier
@en
Olaf Mercier
@es
Olaf Mercier
@nl
type
label
Olaf Mercier
@ast
Olaf Mercier
@en
Olaf Mercier
@es
Olaf Mercier
@nl
prefLabel
Olaf Mercier
@ast
Olaf Mercier
@en
Olaf Mercier
@es
Olaf Mercier
@nl
P106
P31
P496
0000-0002-4760-6267